Solid-phase syntheses of two deacetyl-thymosin β4 analogues with substitution at position 12 and their effects on impaired blastogenic response of T lymphocytes of uremic patients

Drug Development and Industrial Pharmacy

Volumn 22, Issue 8, 1996, Pages 805-811

  Abiko, Takashi ^a   Sekino, Hiroshi ^b  

^a Kidney Research Laboratory   (Japan)

^b Kidney Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEACETYLTHYMOSIN BETA4; PHYTOHEMAGGLUTININ; SYNTHETIC PEPTIDE; THYMOSIN BETA4; THYMOSIN BETA4 DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION; LYMPHOCYTE TRANSFORMATION; PROTEIN SYNTHESIS; T LYMPHOCYTE; UREMIA;

EID: 0029779688     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049609065910     Document Type: Article

References (12)

1. J. M. Boulton-Jones, R. Vick, J. S. Cameron, and P. J. Black, Immune response in uremia, Clin. Nephrol., 1, 351 (1973).
2. W. E. C. Wilson, C. H. Kirkpatrick, and D. W. Talmage, Suppression of immunologic responsiveness in uremia, Ann. Intern. Med., 62, 1 (1965).
3. 4: Synthesis and effect on the impaired peripheral T-cell subsets in patients with chronic renal failure, Chem. Pharm. Bull., 32, 4497 (1984).
4. 10 and examination of its immunological effect on T-cell subpopulations of a uremic patient with tuberculosis, Chem. Pharm. Bull., 34, 4708 (1986).
5. 7 and examination of its immunological effect on the blastogenic response of T-lymphocytes of a uremic patient with cell-mediated immunodeficiency, Chem. Pharm. Bull., 36, 700 (1988).
6. H. Dobbelstein, Immune system in uremia, Nephron, 17, 409 (1976).
7. J. Harris, D. Sengar, A. Rashid, D. Hyslop, and L. Green, Preliminary evidence for thymosin defieciency, Transplantation, 20, 176 (1975).
8. 4: A thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. USA, 98, 1162 (1981).
9. 4, Proc. Natl. Acad. Sci. USA, 97, 1708 (1982).
10. 2 and its effect on the impaired T-cell subsets in patients with lupus nephritis, Chem. Pharm. Bull., 31, 1320 (1983).
11. 9 and its effect on low E-rosette-forming cells of a patient with lupus nephritis, J. Appl. Biochem., 4, 449 (1982).
12. 4 analogue and its restorative effect on depressed, Mediators of Inflammation, 1, 113 (1992).